Research programme: speech disorders therapeutics - National Institute of Neurological Disorders and Stroke/Vivera Biosciences
Latest Information Update: 07 Jun 2022
At a glance
- Originator National Institute of Neurological Disorders and Stroke; Vivera BioSciences
- Class Behavioural disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Speech disorders